Atlas Trials

Real-World Comparison of Chemo-Immunotherapy Regimens in Metastatic NSCLC With PD-L1 <50% (ALCG-01)

Clinical trial NCT07394062 · RECRUITING

Trial details

NCT number
NCT07394062
Sponsor
Gazi University
Status
RECRUITING
Study type
OBSERVATIONAL
Nonsmall Cell Lung Cancer, Stage IVMetastatic Nonsmall Cell Lung Cancer
Start date
2026-02-01
Primary completion
2027-08-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.